IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Virtus Advisers, LLC

Q4 2018 Holdings

Filed 2019-02-05 | 307 holdings | $5.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Autolus Therapeutics PLC(AUTL)SPON ADS05280R100$312.0K9,5025.4%
Beigene LTD(ONC)SPONSORED ADR07725L102$316.0K2,2505.5%
Adaptimmune Therapeutics PLC(ADAPY)SPONDS ADR00653A107$335.0K58,2235.8%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$532.0K11,5319.2%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$549.0K6,4539.5%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$573.0K7,8639.9%
Biogen Inc(BIIB)COM09062X103$574.0K1,9099.9%
PreviousPage 7 of 7